• Politics
  • Diversity, equity and inclusion
  • Financial Decision Making
  • Telehealth
  • Patient Experience
  • Leadership
  • Point of Care Tools
  • Product Solutions
  • Management
  • Technology
  • Healthcare Transformation
  • Data + Technology
  • Safer Hospitals
  • Business
  • Providers in Practice
  • Mergers and Acquisitions
  • AI & Data Analytics
  • Cybersecurity
  • Interoperability & EHRs
  • Medical Devices
  • Pop Health Tech
  • Precision Medicine
  • Virtual Care
  • Health equity

Healthy.io Bags $18M in Funding for Smartphone Urinalysis Kit


The urinalysis kit provides an end-to-end service for users.

Thumbnail and image above have been modified. Courtesy of Healthy.io.

Israel-based Healthy.io has raised $18 million in Series B funding to help scale the company’s home testing service based on its U.S. Food and Drug Administration (FDA)-cleared smartphone urinalysis kit.

The urinalysis kit is aimed at cutting costs related to kidney disease and decreasing the burden of kidney disease complications.

The kit provides an end-to-end service for users, who can use their smartphone camera to scan a dipstick. The results of the urinalysis are then sent directly to doctors and integrated with existing medical records.

>> READ: Unnecessary Testing Proves Costly for Patients With Type 2 Diabetes

With one in three American adults at risk of kidney disease and 100,000 developing kidney failure every year, the disease is costing Medicare $114 billion annually. And early detection can help patients avoid complications from the disease. But testing inefficiencies reduce the number of patients that undergo proper testing.

Healthy.io’s platform could allow patients to have a more readily available, cost-efficient tool to check their urine proteins.

The testing service was assessed by Geisinger Health and the U.S. National Kidney Foundation and achieved a 71 percent adherence rate among patients with hypertension who had never been tested before. The urinalysis can detect previously unidentified kidney disease and can give patients a chance to reduce the elevated risk of complications.

“We know that most patients with kidney disease and protein in their urine are untested and therefore go undiagnosed,” said Joe Coresh, M.D., Ph.D., professor of epidemiology, medicine and biostatistics at Johns Hopkins University in Maryland. “Healthy.io’s user-friendly smartphone technology — directly connecting patients at home with the medical system — is a gamechanger addressing a big need,” he added.

The funding was led by Aleph, with contributions from Samsung NEXT and private investors and follows company milestones that include FDA clearance of the kit and a partnership with Siemens Healthineers.

Get the best insights in healthcare analytics directly to your inbox.


Fertility Focus Raises $2.7M for Real-Time, Predictive Tech

First-of-its-Kind AI Tool for Diabetic Retinopathy Detection Approved by FDA

Vaping Is Still Not a Digital Health Solution

Related Videos
Image: Ron Southwick, Chief Healthcare Executive
George Van Antwerp, MBA
Edmondo Robinson, MD
Craig Newman
© 2024 MJH Life Sciences

All rights reserved.